Showing results (51-60 of 108) with videos related to
Sort By:
Pageof 11
Biorxiv : the Preprint Server for Biology|May 5, 2021
A broadly neutralizing antibody protects against SARS-CoV, pre-emergent bat CoVs, and SARS-CoV-2 variants in miceDavid R Martinez, Alexandra Schaefer, Sophie Gobeil, et al.Science Translational Medicine|April 29, 2016
Initiation of immune tolerance-controlled HIV gp41 neutralizing B cell lineagesRuijun Zhang, Laurent Verkoczy, Kevin Wiehe, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 17, 2016
HIV-1 Envelope Mimicry of Host Enzyme Kynureninase Does Not Disrupt Tryptophan MetabolismTodd Bradley, Guang Yang, Olga Ilkayeva, et al.Journal of Virology|August 13, 2024
Comparison of the immunogenicity of mRNA-encoded and protein HIV-1 Env-ferritin nanoparticle designsZekun Mu, Jill Whitley, Diana Martik, et al.Cell Reports|January 4, 2016
Structural Constraints of Vaccine-Induced Tier-2 Autologous HIV Neutralizing Antibodies Targeting the Receptor-Binding SiteTodd Bradley, Daniela Fera, Jinal Bhiman, et al.Proceedings of the National Academy of Sciences of the United States of America|March 23, 2026
Recurrent SARS-CoV-2 Omicron broadly neutralizing humanized antibodies in different single human VH1-2-rearranging mouse modelsHimanshu Batra, Sai Luo, Kevin O Saunders, et al.Journal of Virology|November 16, 2018
Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVACKaren V Kibler, Benedikt Asbach, Beatriz Perdiguero, et al.Cell Reports|March 16, 2022
mRNA-encoded HIV-1 Env trimer ferritin nanoparticles induce monoclonal antibodies that neutralize heterologous HIV-1 isolates in miceZekun Mu, Kevin Wiehe, Kevin O Saunders, et al.NPJ Vaccines|April 10, 2021
Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primatesKevin O Saunders, Norbert Pardi, Robert Parks, et al.Vaccines|April 23, 2025
Computationally Selected Multivalent HIV-1 Subtype C Vaccine Protects Against Heterologous SHIV ChallengeDieter Mielke, Marina Tuyishime, Natasha S Kelkar, et al.Pageof 11